AmerisourceBergen Announces Date and Time for Fiscal Second Quarter Earnings Release

VALLEY FORGE, Pa.--(Business Wire)--
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to
release its results for the Second Quarter of Fiscal Year 2010 on Thursday,
April 22, 2010 prior to the opening of trading on the New York Stock Exchange.
The Company will host a conference call to discuss the results at 11:00 a.m.
Eastern Daylight Time on April 22, 2010.

Participating in the conference call will be:

R. David Yost, President & Chief Executive Officer
Michael D. DiCandilo, Executive Vice President & Chief Financial Officer

The dial-in number for the live call will be 210-234-0010. The access code for
the call is ABC.

The live call will also be webcast via the Company`s website at
www.amerisourcebergen.com. Users are encouraged to log on to the webcast
approximately 10 minutes in advance of the scheduled start time of the call.

Replays of the call will be made available via telephone and webcast. A replay
of the webcast will be posted on www.amerisourcebergen.com approximately two
hours after the completion of the call and will remain available for thirty
days. The telephone replay will also be available approximately two hours after
the completion of the call and will remain available for seven days. To access
the telephone replay from within the US, dial 866-427-6406. From outside the US,
dial 203-369-0895. No access code is required for the replay.

About AmerisourceBergen

AmerisourceBergen is one of the world's largest pharmaceutical services
companies serving the United States, Canada and selected global markets.
Servicing both pharmaceutical manufacturers and healthcare providers in the
pharmaceutical supply channel, the Company provides drug distribution and
related services designed to reduce costs and improve patient outcomes.
AmerisourceBergen's service solutions range from pharmacy automation and
pharmaceutical packaging to reimbursement and pharmaceutical consulting
services. With more than $70 billion in annual revenue, AmerisourceBergen is
headquartered in Valley Forge, PA, and employs approximately 10,000 people.
AmerisourceBergen is ranked #26 on the Fortune 500 list. For more information,
go to www.amerisourcebergen.com.

FORWARD-LOOKING STATEMENTS

Certain of the statements contained in this press release are "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These statements are based
on management`s current expectations and are subject to uncertainty and change
in circumstances. Among the factors that could cause actual results to differ
materially from those projected, anticipated or implied are the following:
changes in pharmaceutical market growth rates; the loss of one or more key
customer or supplier relationships; changes in customer mix; customer
delinquencies, defaults or insolvencies; supplier defaults or insolvencies;
changes in pharmaceutical manufacturers` pricing and distribution policies or
practices; adverse resolution of any contract or other dispute with customers or
suppliers; federal and state government enforcement initiatives to detect and
prevent suspicious orders of controlled substances and the diversion of
controlled substances; qui tam litigation for alleged violations of laws and
regulations governing the marketing, sale and purchase of pharmaceutical
products; changes in U.S. legislation or regulatory action affecting
pharmaceutical product pricing or reimbursement policies, including under
Medicaid and Medicare; changes in regulatory or clinical medical guidelines
and/or labeling for the pharmaceutical products we distribute, including certain
anemia products; price inflation in branded pharmaceuticals and price deflation
in generics; greater or less than anticipated benefit from launches of the
generic versions of previously patented pharmaceutical products; significant
breakdown or interruption of our information technology systems; our inability
to implement an enterprise resource planning (ERP) system to handle business and
financial processes within AmerisourceBergen Drug Corporation`s operations and
our corporate functions without operating problems and/or cost overruns; success
of integration, restructuring or systems initiatives; interest rate and foreign
currency exchange rate fluctuations; economic, business, competitive and/or
regulatory developments in Canada, the United Kingdom and elsewhere outside of
the United States, including potential changes in Canadian provincial
legislation affecting pharmaceutical product pricing or service fees or
regulatory action by provincial authorities in Canada to lower pharmaceutical
product pricing or service fees; the impact of divestitures or the acquisition
of businesses that do not perform as we expect or that are difficult for us to
integrate or control; our inability to successfully complete any other
transaction that we may wish to pursue from time to time; changes in tax
legislation or adverse resolution of challenges to our tax positions; increased
costs of maintaining, or reductions in our ability to maintain, adequate
liquidity and financing sources; volatility and deterioration of the capital and
credit markets; and other economic, business, competitive, legal, tax,
regulatory and/or operational factors affecting our business generally. Certain
additional factors that management believes could cause actual outcomes and
results to differ materially from those described in forward-looking statements
are set forth (i) in Item 1A (Risk Factors) in the Company's Annual Report on
Form 10-K for this Fiscal Year Ended September 30, 2009 and elsewhere in that
report and (ii) in other reports filed by the Company pursuant to the Securities
Exchange Act of 1934.

AmerisourceBergen Corporation
Michael N. Kilpatric, 610-727-7118
mkilpatric@amerisourcebergen.com

Copyright Business Wire 2010